Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Caused by 15 Serotypes Pharmaceutical Investing
AbbVie Provides Update Regarding RINVOQ® for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S. Biotech Investing
Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma of the Head and Neck Biotech Investing
Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021 Biotech Investing
Johnson & Johnson Faces Class-Action Lawsuit Over Benzene-Tainted Neutrogena and Aveeno Sunscreen Products Medical Device Investing
KEYTRUDA® Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Showed Statistically Significant Event-Free Survival Result Versus Neoadjuvant Chemotherapy Alone in High-Risk Early-Stage TNBC Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Johnson & Johnson Investigation Medical Device Investing
Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene Medical Device Investing
Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board Cannabis Investing News
Gilead to Present New Data at IAS 2021 Demonstrating the Company's Commitment to Advancing Innovation in HIV Research Biotech Investing
Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes Medical Device Investing
